Press Release: RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
APOLLO BEACH, Fla. and HUNTINGTON, W.Va., Oct. 01, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurposed drug development for early detection and treatment of eye and systemic diseases, and RGEN Inc., a leader in genetic research and innovation…
PANAMA CITY, Nov. 19, 2025 (GLOBE NEWSWIRE) -- 2025 marked a decisive year for HTX DAO, a year in which its strategic blueprint transformed into tangible outcomes, and its value cycle began to take shape.
EDINBURGH, United Kingdom, Nov. 19, 2025 (GLOBE NEWSWIRE) -- A pioneering biotech company using fungal technology to enhance tree growth and survival rates is set to expand into North America after raising $5.5 million (£4.5 million) in fresh investment.
The prospectus supplement, the corresponding base shelf prospectus and any amendment thereto in connection with the offering of Canadian Notes will be accessible through SEDAR+ within two business days.
NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Stride, Inc. (“Stride” or the “Company”) (NYSE:LRN) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action…
OCEANSIDE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range…
